LIVONIA, Michigan, January 9, 2017. ARCH Global Precision (“ARCH”), a Strength Capital Partners and Main Post Partners platform company that is focused on manufacturing precision cutting tools, precision machined industrial components and medical implants and instruments, has acquired Seabrook International, LLC (“Seabrook”), located in Seabrook, New Hampshire. Seabrook is a manufacturer of highly-engineered, complex, precision machined medical instruments and implants across multiple orthopedic product groups such as spine, knee, extremities and trauma. Seabrook participates on several of its customers’ flagship programs, and in addition, has a dedicated Make-to-Order and Specialty Products group to support OEM’s with surgeon requested and case specific instruments, implants and prototypes. Seabrook’s customer base comprises the majority of the top 10 global medical OEM’s, plus various other high growth smaller medical companies.
“Seabrook represents our 3rd medical acquisition over the past 10 months as we continue to gain critical mass in this end market. This latest acquisition confirms our commitment to building a medical business with vast capabilities, a breadth of product offerings and a diverse customer base. Seabrook strengthens our existing capabilities in the manufacturing of complex single and multi-assembly instruments, in addition to adding a broader range of implants for various types of medical procedures we have not supported in the past,” commented Eli Crotzer, ARCH Global Precision President and Chief Executive Officer. “Seabrook has a highly skilled and experienced management team who we look forward to partnering with during the next stage of growth. Moreover, Seabrook’s current President and CEO, Paul Barck, is assuming the role of Divisional President of ARCH Medical Solutions,” concluded Mr. Crotzer.
Mr. Barck commented, “I am excited to announce the sale of Seabrook to ARCH Global Precision. Having known Eli and ARCH Global Precision for the last several years, it was an easy decision for us to choose ARCH as the best partner for Seabrook given the cultural alignment and commitment to supporting the future growth of Seabrook. Furthermore, I am pleased to accept the role of Divisional President of ARCH Medical Solutions, and I am excited to provide leadership for this important segment within the ARCH organization.”